Raptor Pharmaceutical Reports First Quarter 2015 Financial Results and Provides Corporate Update
May 07, 2015 16:04 ET
|
Raptor Pharmaceutical Inc
Reports PROCYSBI® Sales of $20.5 Million in First Quarter
Company to Host Conference Call and Webcast Today at 4:30 p.m. ET/1:30 p.m. PT
NOVATO, Calif., May 7, 2015 (GLOBE NEWSWIRE) --...
PROCYSBI(R) to Receive New Treatment Award From Lysosomal Disease Network at the 11th Annual WORLD Symposium
February 10, 2015 09:51 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Lysosomal Disease Network (LDN) will present Raptor Pharmaceutical with the 2015...
Raptor Pharmaceutical Reports Third Quarter 2014 Financial Results and Provides Corporate Update
November 06, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
Global Net Product Sales for PROCYSBI® of $23.8 Million for Third Quarter 2014
PROCYSBI Revenue of $52.2 Million Reached Through September
2014 PROCYSBI Revenue Guidance of $65-$70 Million...
Raptor Pharmaceutical to Present at Leerink Rare Disease Roundtable
September 23, 2014 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Leerink Rare Disease Roundtable in New York on...
Raptor Pharmaceutical Reports Second Quarter 2014 Financial Results and Provides Corporate Update
August 07, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
Global net product sales for PROCYSBI® of $16.3 million reported for second quarter 2014
Raising net sales guidance for PROCYSBI to $65 to $70 million for 2014
Company to host...
Raptor Pharmaceutical to Present at Upcoming Investor Conference
August 06, 2014 16:09 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Canaccord Genuity Annual Growth Conference in...
Raptor Pharmaceutical to Hold Second Quarter 2014 Financial Results Webcast and Conference Call
July 28, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release second quarter 2014 financial results after market close on Thursday,...
Raptor Pharmaceutical Enters Into $70 Million Financing Transaction and Amended Loan Agreement With HealthCare Royalty Partners
July 01, 2014 17:13 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has entered into agreements for $70 million in funding from HealthCare Royalty...
Data Published in Journal of Pediatrics Demonstrated That PROCYSBI(R) Improved Quality of Life and Preserved Kidney Function in Cystinosis Patients
June 24, 2014 07:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that data from its open label extension study of delayed-release cysteamine bitartrate...
Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update
May 08, 2014 16:05 ET
|
Raptor Pharmaceutical Inc
Reports PROCYSBI® net product sales of $12.1 million in first quarter 2014 and launch of PROCYSBI® in Germany
Company to host conference call and webcast today at 4:30 p.m. EDT...